News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Praveen Kumar Marimuthu: Neoadjuvant dostarlimab for Stage I–III dMMR solid tumors
Praveen Kumar Marimuthu/X
Apr 29, 2025, 09:47

Praveen Kumar Marimuthu: Neoadjuvant dostarlimab for Stage I–III dMMR solid tumors

Praveen Kumar Marimuthu, DM Resident in Medical Oncology at Christian Medical College and Hospital, shared an article by Andrea Cercek, et al. on X:

“Nonoperative Rx of d-MMR tumors NEJM:

Neoadjuvant dostarlimab (500 mg q3w x 6 mo) for Stage I–III dMMR solid tumors (rectal and non-rectal):

  • 4/5 had cCR.
  • 4/5 avoided surgery.
  • 2-yr RFS 92%.
  • No Rx-related deaths.

For prostate, GE.”

Praveen Kumar Marimuthu: Neoadjuvant dostarlimab for Stage I–III dMMR solid tumors

Nonoperative Management of Mismatch Repair–Deficient Tumors.

Journal: The New England Journal of Medicine

Authors: Andrea Cercek, et al.

Praveen Kumar Marimuthu: Neoadjuvant dostarlimab for Stage I–III dMMR solid tumors

More posts featuring Praveen Kumar Marimuthu.

Andrea Cercek cancer Christian Medical College and Hospital fight against cancer Global fight against cancer NEJM neoadjuvant dostarlimab OncoDaily Oncology Praveen Kumar Marimuthu The New England Journal of Medicine.
Special Coverage
Science
Apr 29, 2025, 09:47
Praveen Kumar Marimuthu: Neoadjuvant dostarlimab for Stage I–III dMMR solid tumors
Blog
Apr 29, 2025, 09:33
Naveen Pemmaraju: Azacitidine, Venetoclax and Magrolimab in Newly Diagnosed and Relapsed AML
Blog
Apr 29, 2025, 09:23
Chris Poulios: The Young Cancer Professionals group of the European Cancer Organisation
Blog
Apr 29, 2025, 09:16
Navneet Majhail: Congratulations to Stephen Strickland for presenting first-in-human results of SENTI-202
Blog
Apr 29, 2025, 09:10
Ahmed Magdy Rabea: An incredible privilege to participate in the 4th SOH Conference
Blog
Apr 29, 2025, 09:02
Isabel Mestres Announces Candidacy for NCD Alliance Board of Directors 2025–2027
Blog
Apr 29, 2025, 08:54
Women and Cancer: Prevention, Information and Hope - Yale Cancer Center
Blog
Apr 29, 2025, 08:14
Transforming cancer OUtcomes through Research - Consultancy and analytics: Guy’s Cancer cohort
Blog
Apr 29, 2025, 07:50
Petros Grivas: Congratulations to all speakers at The American Urological Association Meeting
Dialogues
Apr 29, 2025, 07:48
OnCoffee: Brian Chernak on Cancer, Baseball, Architecture, and Work-Life Balance
Blog
Apr 29, 2025, 07:40
Margaret Foti: A pleasure to see everyone at the Korean Researchers Networking Night at AACR25
Dialogues
Apr 29, 2025, 07:34
Empowering Oncologists: How did we set up research infrastructure in the community?